Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC.
Conditions: Non-muscle Invasive Bladder Cancer (NMIBC) Interventions: Device: Hyaluronic Acid (HA) sodium salt and Hydeal-D Sponsors: Fidia Farmaceutici s.p.a. Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials
Sodium-glucose Transport 2 Inhibitors (SGLT2i) in HFrEF Patients
Conditions: Heart Failure; Reduced Ejection Fraction Heart Failure Interventions: Drug: Empagliflozin 10 MG; Drug: Dapagliflozin 10 MG Sponsors: Damanhour University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials
Risk Analysis of Cardiotoxic Medication Use Due to Sodium Arsenite Chloride Injection
Conditions: Adverse Reaction; Cardiotoxicity; Evaluation Study Interventions: Drug: Sodium arsenite chloride injection Sponsors: Qianfoshan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials
The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics
Conditions: Obesity; Type 2 Diabetes; Sodium-glucose Co-transporter-2 Inhibitor; Myocardial Fibrosis; Magnetic Resonance Imaging Interventions: Drug: Henagliflozin; Drug: Metformin Sponsor: RenJi Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Double Blind Trial in Children With Autism Spectrum Disorder
Condition: Autism Spectrum Disorder Intervention: Drug: Suramin Sodium Sponsor: Paxmedica Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Double Blind Trial in Children With Autism Spectrum Disorder
Conditions: Autism Spectrum Disorder Interventions: Drug: Suramin Sodium Sponsors: Paxmedica Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics
Conditions: Obesity; Type 2 Diabetes; Sodium-glucose Co-transporter-2 Inhibitor; Myocardial Fibrosis; Magnetic Resonance Imaging Interventions: Drug: Henagliflozin; Drug: Metformin Sponsors: RenJi Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Identification of Nerves Using Fluorescein Sodium
Conditions: Pleomorphic Adenoma of the Parotid; Warthin Tumor; Head and Neck Disorder Intervention: Drug: Fluorescein Sodium Sponsor: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency
Condition: Ureter Injury Interventions: Drug: Indigotindisulfonate sodium 0.8%; Other: Saline injection 0.9% Sponsor: Prove pharm Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
Identification of Nerves Using Fluorescein Sodium
Conditions: Pleomorphic Adenoma of the Parotid; Warthin Tumor; Head and Neck Disorder Intervention: Drug: Fluorescein Sodium Sponsor: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency
Condition: Ureter Injury Interventions: Drug: Indigotindisulfonate sodium 0.8%; Other: Saline injection 0.9% Sponsor: Prove pharm Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
Identification of Nerves Using Fluorescein Sodium
Conditions: Pleomorphic Adenoma of the Parotid; Warthin Tumor; Head and Neck Disorder Intervention: Drug: Fluorescein Sodium Sponsor: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency
Conditions: Ureter Injury Interventions: Drug: Indigotindisulfonate sodium 0.8%; Other: Saline injection 0.9% Sponsors: Prove pharm Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
Identification of Nerves Using Fluorescein Sodium
Conditions: Pleomorphic Adenoma of the Parotid; Warthin Tumor; Head and Neck Disorder Interventions: Drug: Fluorescein Sodium Sponsors: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
